Baxter to buy bone graft developer for $300 million

Big win for Biologics startups.....and a big win for M&A in Orthopedics in this climate.

Baxter announced that it had acquired Apatech for $330M ($240M upfront plus $90M in earnouts when certain milestones are met).   Apatech is a manufacturer of synthetic bone repair materials, operations in London, England, Foxborough, Massachusetts, USA and Berlin, Germany, and is a world leader in bone graft technologies, selling its products in over 20 countries around the world. ChicagoBreakingNews... http://ow.ly/1dios Baxter Press Release...  http://ow.ly/1di4V Apatech website...   http://www.apat...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top